Promote urination

The term 'Promote urination' refers to a physiological process or a desired clinical outcome rather than a specific molecular target like a receptor, enzyme, or transporter. This effect, often termed diuresis or micturition depending on whether it concerns urine production or bladder emptying, is a primary therapeutic goal in treating conditions like hypertension and congestive heart failure. Drugs that achieve this effect act on a variety of distinct molecular targets, including the Solute carrier family 12 member 1 (NKCC2) in the kidneys or Muscarinic acetylcholine receptors in the bladder wall (NIH: StatPearls, 2023). Because it describes a broad functional result of several different pharmacological pathways, it is considered an incorrect designation for a single therapeutic target. In a biotech and drug discovery context, identifying the specific protein or pathway responsible for the diuretic or pro-micturition effect is necessary for target-based drug design.

Other names

DiuresisMicturitionIncreased urine outputDiuretic effect

Promotion of urination is achieved by pharmacological agents through various mechanisms, such as inhibiting sodium-potassium-chloride symporters in the thick ascending limb of the loop of Henle (loop diuretics), inhibiting sodium-chloride symporters in the distal convoluted tubule (thiazides), or agonism of muscarinic M3 receptors in the bladder to stimulate detrusor muscle contraction (StatPearls: Diuretics, 2023; StatPearls: Physiology, Urination, 2023).